Drug intelligence / Profile preview

isobutyl nitrite

Development stage
Unknown
Modality
Small Molecules
Administration
Inhalation
01

Overview

**Isobutyl nitrite** is a small molecule alkyl nitrite compound with the chemical formula C4H9NO2 and structure (CH3)2CH-CH2-ONO. It acts as a vasodilator by spontaneously releasing nitric oxide (NO), which activates soluble guanylate cyclase, increases cyclic GMP levels, and causes relaxation of smooth muscle and dilation of blood vessels. Historically noted in the late 1890s by physician Thomas Lauder Brunton for vasodilating effects similar to amyl nitrite, it was never developed as a clinical therapeutic alternative. Isobutyl nitrite became primarily known as a recreational inhalant drug, commonly referred to as 'poppers,' and was sold under street brand names such as 'Rush' and 'Gold Rush,' often marketed as room odorizers or air fresheners. It has also been used as a component of cyanide poisoning antidote packages, where nitrites induce methemoglobin formation to sequester cyanide. Due to carcinogenic concerns arising from animal studies, isobutyl nitrite has been banned in the European Union since 2007 and in the United States since 1990. No pharmaceutical company is currently developing it as a therapeutic agent.

Brand names
RushGold Rush
Other names
2-methylpropyl nitriteisobutyl nitritepoppers
02

Targets

sGC (Soluble Guanylyl Cyclase)

Beyond the preview

Go deeper on isobutyl nitrite.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on isobutyl nitrite.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call